Hereditary pheochromocytoma and paraganglioma: genes and variants
Explore variant evidence for Hereditary pheochromocytoma and paraganglioma across 7 analyzed proteins (TMEM127, SDHAF2, MAX, SDHC, SDHB and 2 more). Linked ClinVar records include 9 pathogenic or likely pathogenic variants, 792 variants of uncertain significance and 60 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Hereditary pheochromocytoma and paraganglioma
TMEM127: Transmembrane protein 127
It restrains growth signaling and participates in endomembrane trafficking, including regulation of mTOR-related pathways. Germline loss-of-function variants predispose primarily to pheochromocytoma and paraganglioma and can also occur in selected renal tumors.
5 ClinVar pathogenic / likely pathogenic and 360 uncertain variants in TMEM127 have source records linked to Hereditary pheochromocytoma and paraganglioma. Association strength is not clinical gene validity.
SDHAF2: Succinate dehydrogenase assembly factor 2, mitochondrial
It is required for covalent flavin attachment and maturation of the SDHA catalytic subunit, enabling normal succinate dehydrogenase activity. Germline loss-of-function variants can predispose to hereditary head-and-neck paragangliomas through functional loss of complex II.
1 ClinVar pathogenic / likely pathogenic and 230 uncertain variants in SDHAF2 have source records linked to Hereditary pheochromocytoma and paraganglioma. Association strength is not clinical gene validity.
MAX: Protein max
It forms DNA-binding dimers with MYC-family proteins and other partners, balancing transcriptional programs that promote or restrain proliferation. Germline loss-of-function variants predispose to pheochromocytoma and paraganglioma, while altered MAX-MYC signaling is central to many cancers.
1 ClinVar pathogenic / likely pathogenic and 153 uncertain variants in MAX have source records linked to Hereditary pheochromocytoma and paraganglioma. Association strength is not clinical gene validity.
SDHC: Succinate dehydrogenase cytochrome b560 subunit, mitochondrial
It anchors succinate dehydrogenase to the inner mitochondrial membrane and helps transfer electrons from the catalytic subunits to ubiquinone. Heterozygous loss-of-function variants predispose to paraganglioma, pheochromocytoma, and some gastrointestinal stromal tumors.
1 ClinVar pathogenic / likely pathogenic and 40 uncertain variants in SDHC have source records linked to Hereditary pheochromocytoma and paraganglioma. Association strength is not clinical gene validity.
SDHB: Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial
It transfers electrons from succinate oxidation through iron-sulfur centers toward ubiquinone in mitochondrial complex II. Heterozygous loss-of-function variants strongly predispose to paraganglioma and pheochromocytoma and can also increase renal-tumor and gastrointestinal-stromal-tumor risk.
1 ClinVar pathogenic / likely pathogenic and 43 uncertain variants in SDHB have source records linked to Hereditary pheochromocytoma and paraganglioma. Association strength is not clinical gene validity.
SDHD: Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial
It provides a membrane-anchoring component of succinate dehydrogenase and is required for normal complex II electron transfer. Germline loss-of-function variants, often showing a parent-of-origin effect, strongly predispose to head-and-neck paragangliomas and pheochromocytomas.
0 ClinVar pathogenic / likely pathogenic and 19 uncertain variants in SDHD have source records linked to Hereditary pheochromocytoma and paraganglioma. Association strength is not clinical gene validity.
SDHA: Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial
It catalyzes oxidation of succinate to fumarate while transferring electrons into respiratory-chain complex II, directly linking the TCA cycle with oxidative phosphorylation. Biallelic deficiency can cause mitochondrial disease, while heterozygous loss-of-function variants predispose to paraganglioma, pheochromocytoma, and selected gastrointestinal stromal tumors.
0 ClinVar pathogenic / likely pathogenic and 5 uncertain variants in SDHA have source records linked to Hereditary pheochromocytoma and paraganglioma. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): DNMT3A.
ClinVar pathogenic and likely pathogenic variants linked to Hereditary pheochromocytoma and paraganglioma
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| TMEM127 M1K | 1 | Pathogenic / likely pathogenic (★★) | |
| TMEM127 M1T | 1 | Pathogenic / likely pathogenic (★★) | |
| TMEM127 M1R | 1 | Pathogenic / likely pathogenic (★★) | |
| TMEM127 M1I | 1 | Pathogenic / likely pathogenic (★★) | |
| TMEM127 M1L | 1 | Pathogenic / likely pathogenic (★★) | |
| SDHAF2 G78R | 78 | Pathogenic / likely pathogenic (★★) | |
| MAX A67D | 67 | bHLH | Pathogenic / likely pathogenic (★★) |
| SDHC M1L | 1 | Pathogenic / likely pathogenic (★★) | |
| SDHB S92P | 92 | 2Fe-2S ferredoxin-type | Pathogenic / likely pathogenic |
Which prediction tools work for Hereditary pheochromocytoma and paraganglioma
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MutPred: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 97 out of 100
- MetaLR: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 87 out of 100
- ESM1b (LLR): 81 out of 100
- PolyPhen-2: 62 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Gastrointestinal stromal tumor also has ClinVar records linked to SDHC variants; they fall mostly in different places as the Hereditary pheochromocytoma and paraganglioma variants (16 pathogenic / likely pathogenic).
- Pheochromocytoma/paraganglioma syndrome also has ClinVar records linked to SDHC variants; they fall mostly in different places as the Hereditary pheochromocytoma and paraganglioma variants (16 pathogenic / likely pathogenic).
- Gastrointestinal stromal tumor also has ClinVar records linked to SDHB variants; they fall mostly in different places as the Hereditary pheochromocytoma and paraganglioma variants (53 pathogenic / likely pathogenic).
- Pheochromocytoma/paraganglioma syndrome also has ClinVar records linked to SDHB variants; they fall mostly in different places as the Hereditary pheochromocytoma and paraganglioma variants (48 pathogenic / likely pathogenic).
- Pheochromocytoma also has ClinVar records linked to SDHB variants; they fall mostly in different places as the Hereditary pheochromocytoma and paraganglioma variants (47 pathogenic / likely pathogenic).
- Carney-Stratakis syndrome also has ClinVar records linked to SDHB variants; they fall mostly in different places as the Hereditary pheochromocytoma and paraganglioma variants (7 pathogenic / likely pathogenic).
- Mitochondrial complex 2 deficiency, nuclear also has ClinVar records linked to SDHB variants; they fall mostly in different places as the Hereditary pheochromocytoma and paraganglioma variants (7 pathogenic / likely pathogenic).
Diseases related to Hereditary pheochromocytoma and paraganglioma
- Pheochromocytoma/paraganglioma syndrome, also linked to SDHA, SDHAF2, SDHB, SDHC and 1 more
- Pheochromocytoma, also linked to MAX, SDHB, SDHD and TMEM127
- Gastrointestinal stromal tumor, also linked to SDHA, SDHB and SDHC
- Carney-Stratakis syndrome, also linked to SDHB, SDHC and SDHD
- Inherited phaeochromocytoma and paraganglioma excluding NF1, also linked to SDHA, SDHB and SDHC
- Mitochondrial complex II deficiency, nuclear, also linked to SDHA and SDHD
- Mitochondrial complex 2 deficiency, nuclear, also linked to SDHB and SDHD
- Cowden syndrome, also linked to SDHD
- Paragangliomas with sensorineural hearing loss, also linked to SDHD
- Multiple myeloma, also linked to MAX
- Neurodegeneration with ataxia and late-onset optic atrophy, also linked to SDHA
- Dilated cardiomyopathy 1GG, also linked to SDHA
Frequently asked questions
Which genes have records linked to Hereditary pheochromocytoma and paraganglioma?
This view contains 7 analyzed proteins: TMEM127, SDHAF2, MAX, SDHC, SDHB and 2 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 9 pathogenic or likely pathogenic variants, 792 variants of uncertain significance and 60 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 866 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center